Clinical application of percutaneous pulmonary valve implantation in patients with pulmonary valve regurgitation / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
;
(24): 318-320, 2020.
Artigo
em Chinês
| WPRIM
| ID: wpr-864002
ABSTRACT
Percutaneous pulmonary valve implantation (PPVI) is applied relatively late in clinical practice in China as an emerging technology, but it has developed rapidly with the increasing clinical attention paid to severe pulmonary valve regurgitation in medical level in China and the clinical appearance of congenital heart disease patients with right ventricular outflow obstruction after surgery.In the past ten years, European and American countries have applied PPVI in clinical practice, which has the advantages of minimally invasive, reproducibility and good postoperative efficacy compared with traditional surgery.The clinical application of PPVI in patients with pulmonary regurgitation is summarized.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Applied Clinical Pediatrics
Ano de publicação:
2020
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS